4.7 Article

The state of complement in COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Thromboinflammation in coronavirus disease 2019: The clot thickens

Raayma Iffah et al.

Summary: The pathophysiology of COVID-19 is complex, with multiple systems contributing to thrombosis and inflammation. Understanding the role of the immune system in different patient cohorts is crucial for developing novel therapeutic targets and drug repurposing strategies.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

Article Hematology

Complement dysregulation is associated with severe COVID-19 illness

Jia Yu et al.

Summary: The serum of COVID-19 patients can induce complement-mediated cell death and is associated with dysregulation of APC, which may contribute to the pathogenesis and severity of the disease.

HAEMATOLOGICA (2022)

Review Pharmacology & Pharmacy

The role of complement in arterial hypertension and hypertensive end organ damage

Ulrich O. Wenzel et al.

Summary: The complement system plays a crucial role in the pathology of hypertension by affecting innate and adaptive immune responses in addition to direct effects on the vasculature. Recent experimental data support the involvement of complement in all stages of arterial hypertension.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Urology & Nephrology

Immunity, endothelial injury and complement-induced coagulopathy in COVID-19

Luca Perico et al.

Summary: This review provides insights into the pathogenic mechanisms and clinical manifestations of COVID-19, highlighting the critical role of the immunological hyper-response induced by SARS-CoV-2 infection. The authors emphasize the importance of early diagnosis and intervention in controlling disease progression.

NATURE REVIEWS NEPHROLOGY (2021)

Review Virology

Clotting disorder in severe acute respiratory syndrome coronavirus 2

Sujit Pujhari et al.

Summary: In severe cases of COVID-19 caused by SARS-CoV-2 infection, blood clotting disorders and acute respiratory failure are major complications, with clotting-associated complications being a major cause of death.

REVIEWS IN MEDICAL VIROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Microthrombi as a Major Cause of Cardiac Injury in COVID-19 A Pathologic Study

Dario Pellegrini et al.

Summary: Analysis of heart tissue from 40 deceased COVID-19 patients revealed that microthrombi were the most common pathological cause of myocyte necrosis. Female patients with chronic kidney disease and shorter symptom onset to admission time were more likely to have myocyte necrosis. Tailored antithrombotic strategies may be useful to counteract the cardiac effects of COVID-19 infection.

CIRCULATION (2021)

Letter Urology & Nephrology

Atypical HUS relapse triggered by COVID-19

Simon Ville et al.

KIDNEY INTERNATIONAL (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cardiac & Cardiovascular Systems

From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19

R. Vinci et al.

Summary: This study concisely reviews the clinical, autopsy, experimental, and molecular data of COVID-19, and highlights the disruption of ACE2 and thromboinflammatory microangiopathy as distinctive features. The entry of the virus into microvessels may trigger significant inflammatory reactions, including thrombosis and organ damage.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Complement Activation in Kidneys of Patients With COVID-19

Frederick Pfister et al.

Summary: Most critically ill patients with COVID-19 develop severe acute respiratory syndrome (SARS) due to maladaptive immune response. The complement system is activated in COVID-19 kidneys, with the lectin pathway mainly involved in peritubular capillaries and the classical pathway in renal arteries. Inhibition of complement activation could be a potential treatment option to prevent renal injury exacerbation.

FRONTIERS IN IMMUNOLOGY (2021)

Article Hematology

Prothrombotic immune thrombocytopenia after COVID-19 vaccination

Andreas Tiede et al.

Summary: This study reports 5 cases of prothrombotic immune thrombocytopenia following vaccination with AZD1222. Patients presented with various clinical manifestations, including thrombocytopenia and elevated D-dimer levels. Treatment experience suggests that anticoagulation may be effective, but there is also a risk of unusual and severe thromboembolic events.
Article Immunology

Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19

Abhigyan Satyam et al.

Summary: Lung inflammation and damage play a significant role in COVID-19 morbidity and mortality. The deposition of complement components in the lungs of COVID-19 patients suggests the activation of classical and alternative pathways, supporting the use of complement inhibitors as a potential treatment strategy.

CLINICAL IMMUNOLOGY (2021)

Editorial Material Hematology

Post-mortem findings in vaccine-induced thrombotic thombocytopenia

Cristoforo Pomara et al.

HAEMATOLOGICA (2021)

Article Immunology

The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts

Jasna Friscic et al.

Summary: Inflammation-mediated tissue priming causes recurrence and worsening of arthritis, involving molecular and cellular mechanisms. This priming occurs locally and independently of adaptive immunity, and can be enhanced by activating complement C3 and C3a receptor, along with other molecular pathways, to boost cellular metabolic activity and increase inflammation sensitivity.

IMMUNITY (2021)

Article Medicine, General & Internal

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021

Isaac See et al.

Summary: Cases of CVST with thrombocytopenia following Ad26.COV2.S vaccination have been reported in the US, leading to serious outcomes. This case series may provide guidance for clinical management and further investigation into the potential relationship between Ad26.COV2.S vaccine and CVST with thrombocytopenia.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, General & Internal

Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic

E. S. Romanova et al.

Summary: Assessment of the association between COVID-19 and cause of death was hindered by limited autopsies. However, the study found that a vast majority of PCR-positive fatalities during the pandemic were related to diffuse alveolar damage caused by COVID-19. Pulmonary artery thrombosis and pulmonary tissue microangiopathy were common in these cases, while venous pulmonary embolism was rarely observed.

JOURNAL OF INTERNAL MEDICINE (2021)

Article Multidisciplinary Sciences

The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery

Eleni Syrimi et al.

Summary: Children with Multisystem Inflammatory Syndrome in Children (MIS-C) show highly activated immune cells during acute phase, which changes as they recover with increased levels of certain immune markers. Plasma profiling suggests potential treatment options and mechanisms of action, such as inhibition of IL-6 and complement activation.

ISCIENCE (2021)

Article Pathology

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

Clare Bryce et al.

Summary: The study reports the first 100 COVID-19-positive autopsies performed in New York City, revealing widespread effects including diffuse alveolar damage, large pulmonary emboli, microthrombi in multiple organ systems, and presence of the virus in samples. Laboratory results showed elevated inflammatory markers, abnormal coagulation values, and increased cytokines.

MODERN PATHOLOGY (2021)

Article Multidisciplinary Sciences

COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets

Toni M. Delorey et al.

Summary: This study using single-cell and spatial atlases revealed the impact of COVID-19 infection on lung, kidney, liver, and heart tissues, showing structural remodeling and viral RNA enrichment. Differences in lung inflammatory responses and transcriptional alterations in heart tissue of COVID-19 patients were also identified, along with cell types and genes associated with disease severity.

NATURE (2021)

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination

Kate-Lynn Muir et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination

Andreas Greinacher et al.

Summary: After vaccination with ChAdOx1 nCov-19, rare immune thrombotic thrombocytopenia can occur due to platelet-activating antibodies against PF4, resulting in various thrombotic events. Most patients in this case series were women, with fatal outcomes such as cerebral venous thrombosis and intracranial hemorrhage. Additional studies are needed to further investigate and understand this phenomenon.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Medicine, General & Internal

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination - Response from the Manufacturer

Jerald Sadoff et al.

Summary: The manufacturer responds to recent reports of thrombosis and severe thrombocytopenia in recipients of the Ad26.COV2.S vaccine.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Immunology

Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection

Gyorgy Sinkovits et al.

Summary: Uncontrolled complement activation is associated with advanced disease severity of COVID-19, with patients more likely to die when accompanied by overactivation and consumption of C3. These findings support the potential use of complement inhibitory drugs in the treatment of COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Editorial Material Urology & Nephrology

Kidney Thrombotic Microangiopathy After COVID-19 Associated With C3 Gene Mutation

Olivier Mat et al.

KIDNEY INTERNATIONAL REPORTS (2021)

Editorial Material Microbiology

An aberrant inflammatory response in severe COVID-19

Miriam Merad et al.

Summary: Severe COVID-19 results from a combination of inadequate pre-existing immunity and host responses that damage rather than repair tissues. The study outlines clinical presentations likely driven by dysregulated host immunity, discusses potential mechanisms, and emphasizes important areas for basic research on this topic.

CELL HOST & MICROBE (2021)

Article Medicine, General & Internal

Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality

Francesco Violi et al.

Summary: Through a multi-center analysis, it was found that Covid-19 patients have a high rate of both venous and arterial thrombotic events, which are associated with poor survival. Early identification and appropriate treatment of Covid-19 patients at risk for thrombosis may improve prognosis.

INTERNAL AND EMERGENCY MEDICINE (2021)

Article Medicine, General & Internal

Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis

Manu Shankar-Hari et al.

Summary: This study identified 27 clinical trials and found that the use of IL-6 antagonists was associated with lower 28-day all-cause mortality in patients hospitalized for COVID-19 compared to usual care or placebo. Different risk effects were observed between tocilizumab and sarilumab, increasing understanding of the treatment with these drugs.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Biochemistry & Molecular Biology

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou et al.

Summary: The SAVE-MORE phase 3 study demonstrated the efficacy of anakinra, an IL-1 alpha/beta inhibitor, in patients with COVID-19 and high serum levels of soluble plasminogen activator receptor, showing significant reduction in clinical deterioration and decreased 28-day mortality.

NATURE MEDICINE (2021)

Article Immunology

Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins

Youssif M. Ali et al.

Summary: Early and persistent complement activation is crucial in the pathogenesis of COVID-19, leading to a series of pathological events that trigger severe inflammatory responses to SARS-CoV-2. Research targeting MASP-2 suggests that the LP pathway of the complement system could offer a therapeutic window for treating severe COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

Felipe Perez-Garcia et al.

Summary: Both EASIX and aEASIX-COVID were associated with death within 28 days in hospitalized COVID-19 patients, with aEASIX-COVID showing significantly better predictive performance than EASIX, particularly for discarding death.

FRONTIERS IN MEDICINE (2021)

Article Immunology

Endothelial cells are not productively infected by SARS-CoV-2

Lilian Schimmel et al.

Summary: The study suggests that primary human endothelial cells express low levels of the SARS-CoV-2 receptor and protease, limiting their susceptibility to infection unless overexpressing ACE2 or exposed to high viral concentrations. Endothelial cells are unlikely to be infected in 3D vessels under flow conditions but respond to infection in adjacent epithelial cells by increasing ICAM-1 expression and releasing pro-inflammatory cytokines.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Letter Infectious Diseases

An interactive web-based dashboard to track COVID-19 in real time

Ensheng Dong et al.

LANCET INFECTIOUS DISEASES (2020)

Editorial Material Hematology

Balanced translocations in myelodysplastic syndromes (MDS) - an unrecognised MDS patient subgroup?

Moshe Mittelman

BRITISH JOURNAL OF HAEMATOLOGY (2020)

Article Biochemistry & Molecular Biology

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Bo Shen et al.

Editorial Material Cardiac & Cardiovascular Systems

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

Luka Nicin et al.

EUROPEAN HEART JOURNAL (2020)

Article Allergy

Complement activation in patients with COVID-19: A novel therapeutic target

Massimo Cugno et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Immunology

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Betsy J. Barnes et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Letter Infectious Diseases

Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact

Fabrizio Cantini et al.

JOURNAL OF INFECTION (2020)

Editorial Material Medicine, General & Internal

Covid-19: risk factors for severe disease and death

Rachel E. Jordan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Review Urology & Nephrology

The case of complement activation in COVID-19 multiorgan impact

Marina Noris et al.

KIDNEY INTERNATIONAL (2020)

Article Medicine, General & Internal

Hyperinflammatory shock in children during COVID-19 pandemic

Shelley Riphagen et al.

LANCET (2020)

Letter Medicine, General & Internal

Endothelial cell infection and endotheliitis in COVID-19

Zsuzsanna Varga et al.

LANCET (2020)

Article Critical Care Medicine

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans

Sharon E. Fox et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Multidisciplinary Sciences

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Sin Fun Sia et al.

NATURE (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Immunology

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Sara Mastaglio et al.

CLINICAL IMMUNOLOGY (2020)

Editorial Material Hematology

Endothelial cells orchestrate COVID-19 coagulopathy Comment

Jamie M. O'Sullivan et al.

LANCET HAEMATOLOGY (2020)

Article Medicine, General & Internal

Vascular occlusion by neutrophil extracellular traps in COVID-19

Moritz Leppkes et al.

EBIOMEDICINE (2020)

Letter Critical Care Medicine

Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19

Wioleta M. Zelek et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Multidisciplinary Sciences

Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis

Julien Carvelli et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection

Vijendra Ramlall et al.

NATURE MEDICINE (2020)

Article Immunology

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

Jeffrey Laurence et al.

CLINICAL IMMUNOLOGY (2020)

Article Medicine, Research & Experimental

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Panagiotis Skendros et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Jan C. Holter et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Medicine, Research & Experimental

Baricitinib restrains the immune dysregulation in patients with severe COVID-19

Vincenzo Bronte et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Immunology

I mmunosenescence and Inflammaging: Risk Factors of Severe COVID-19 in Older People

Anna Julia Pietrobon et al.

FRONTIERS IN IMMUNOLOGY (2020)

Editorial Material Cardiac & Cardiovascular Systems

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

Luka Nicin et al.

EUROPEAN HEART JOURNAL (2020)

Review Immunology

NETosis, complement, and coagulation: a triangular relationship

Cynthia M. de Bont et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2019)

Article Biochemistry & Molecular Biology

Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death

Hrishikesh S. Kulkarni et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Review Endocrinology & Metabolism

Complement Components, C3 and C4, and the Metabolic Syndrome

Melanie Copenhaver et al.

CURRENT DIABETES REVIEWS (2019)

Article Urology & Nephrology

C5b9 Formation on Endothelial Cells Reflects Complement Defects among Patients with Renal Thrombotic Microangiopathy and Severe Hypertension

Sjoerd A. M. E. G. Timmermans et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)

Article Multidisciplinary Sciences

Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism

Giuseppina Arbore et al.

NATURE COMMUNICATIONS (2018)

Article Medicine, General & Internal

Paroxysmal nocturnal haemoglobinuria

Anita Hill et al.

NATURE REVIEWS DISEASE PRIMERS (2017)

Review Immunology

Novel mechanisms and functions of complement

George Hajishengallis et al.

NATURE IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells

Giuseppina Arbore et al.

SCIENCE (2016)

Review Biochemistry & Molecular Biology

A vital role for complement in heart disease

Knut T. Lappegard et al.

MOLECULAR IMMUNOLOGY (2014)

Review Immunology

Understanding immunosenescence to improve responses to vaccines

Joerg J. Goronzy et al.

NATURE IMMUNOLOGY (2013)

Review Urology & Nephrology

Overview of Complement Activation and Regulation

Marina Noris et al.

SEMINARS IN NEPHROLOGY (2013)

Article Biochemistry & Molecular Biology

Complement C1q Activates Canonical Wnt Signaling and Promotes Aging-Related Phenotypes

Atsuhiko T. Naito et al.

Article Medicine, Research & Experimental

Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury

Axelle Caudrillier et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Urology & Nephrology

STEC-HUS, atypical HUS and TTP are all diseases of complement activation

Marina Noris et al.

NATURE REVIEWS NEPHROLOGY (2012)

Article Ophthalmology

Complement Component C5a Activates ICAM-1 Expression on Human Choroidal Endothelial Cells

Jessica M. Skeie et al.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)

Article Biochemistry & Molecular Biology

Extracellular histones are major mediators of death in sepsis

Jun Xu et al.

NATURE MEDICINE (2009)

Article Ophthalmology

Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions

Alexander F. Scheuerle et al.

INTERNATIONAL OPHTHALMOLOGY (2008)

Article Immunology

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection

WKE Ip et al.

JOURNAL OF INFECTIOUS DISEASES (2005)

Review Medicine, General & Internal

Advances in immunology: Complement (First of two parts).

MJ Walport

NEW ENGLAND JOURNAL OF MEDICINE (2001)

Article Pathology

In situ localization of C3 synthesis in experimental acute renal allograft rejection

JR Pratt et al.

AMERICAN JOURNAL OF PATHOLOGY (2000)